Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwCLL 2019 | The impact of regulatory RNA molecules

Marek Mráz • 20 Sep 2019
iwCLL 2019
Chronic Lymphocytic Leukemia Leukemia

Marek Mráz, MD, PhD, Central European Institute of Technology & University Hospital, Brno, Czech Republic, discusses the impact of regulatory RNA molecules in chronic lymphocytic leukemia (CLL). This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

More from Marek Mráz

2:01
Transcription factor FoxO1 mediates cell survival during BCR inhibitor therapy in CLL
Marek Mráz • 7 Oct 2023
1:01
CLL resistance mechanisms in the era of novel agents
Marek Mráz • 7 Oct 2023

Related Videos

1:17
The curative potential of alloSCT in the treatment of HR-MDS
Jurjen Versluis • 22 Apr 2024
10:34
Remission induction therapy prior to alloSCT in AML: insights from the ASAP trial
Johannes Schetelig • 19 Apr 2024
1:57
The FORUM trials: results of F1 and plans for F2
Christina Peters • 15 Apr 2024
5:28
Young matched unrelated donors versus older-aged matched sibling donors in alloSCT with PTCy
Karthik Nath • 17 Apr 2024
The content of VJHemOnc is intended for healthcare professionals